NASDAQ · EUDA
EUDA Health Holdings Limited
Healthcare · Medical - Care Facilities
$16.98▲ 6.69% ($1.06)at close
After hours$16.70▼ 1.62%7:30 PM ET
Market cap
$31.70M
P/E
N/M
EPS (TTM)
-$2.56
Next earnings
Mar 3, 2027
Valuation
Revenue & margin DCF
Verdict: expensive. Price above all scenarios.
The price needs 24.7% revenue growth a year for 10 years. Our scenarios assume 14.1–24.4%.
That's 2.3× its past 4-year pace.
Value per share
Base case
$10.53
Price used $16.98 is 1.6× this
USD · TTM ending Dec 31, 2025 · Price Oct 2, 7:59 PM UTC
Reported operating earnings and the comparable cash-flow estimate differ substantially; the model retains the reported-margin anchor.
Revenue each value needs
Revenue today $6.8M. The price needs $61.8M by 2035. Base case: $40.9M. At its recent pace: $18.7M. Bear to Bull: $25.4M to $60.7M.
Revenue today $6.8M. The price needs $61.8M by 2035. Base case: $40.9M. At its recent pace: $18.7M. Bear to Bull: $25.4M to $60.7M.
Revenue in 2035
today $6.8M
+$21Mmore than the Base case · 1.5×
Value per share · Base case
$10.53
Price $16.98
1.6× this
- 10-yr revenue CAGR
- 19.6%
- Ending operating margin
- 0.0%
- Discount rate
- 8.9%
Reported operating earnings and the comparable cash-flow estimate differ substantially; the model retains the reported-margin anchor.
USD · TTM ending Dec 31, 2025 · Price Oct 2, 7:59 PM UTC
What each scenario assumes. Click a column to start from it.
Price vs Fundamentals
Why The Stock Is Moving
Note: The latest financial period used here ended about 9 months ago, so a newer report is probably out. Metrics shown may not reflect it.
What changed
The stock fell 58.16% over the last year. Revenue grew 70.04% in FY2025 versus FY2024. Operating margin moved from -432.19% to -35.78% (FY2025 versus FY2024). Free cash flow declined 17.68% in FY2025 versus FY2024.
What the market seems to be pricing
Visible fundamentals weakened far less than the stock price. The market appears to be discounting durability, risk, or trust rather than just the latest reported numbers.
What would invalidate this read
This read changes if operating margin (currently -35.78%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Return analysis
Company profile
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China.
Market multiples
Stock splits
Every 20 shares became 1
Profitability & growth
Analyst consensus
1
Buy
0
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Mar 3, 2027
Q1 FY26 · EPS est $1.20 · Revenue est $17.62M
View
Institutional Sentiment
EUDA Health Holdings Limited · EUDA
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.